Back to Search
EDWARD COPELAN, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1962417451Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
2012-02388(NC)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
2012-02388(NC)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
2012-02388(NC)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
2012-02388(NC)
Research & Publications (20)
Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia.
PMID 19539217·Biol Blood Marrow Transplant·2009
3-trial
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.
PMID 18794865·Bone Marrow Transplant·2009
2-rct
A scheme for defining cause of death and its application in the T cell depletion trial.
PMID 18022577·Biol Blood Marrow Transplant·2007
4-observational
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
PMID 15156164·Bone Marrow Transplant·2004
3-trial
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation.
PMID 11551021·Bone Marrow Transplant·2001
8-other
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma.
PMID 10871728·Bone Marrow Transplant·2000
3-trial
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy.
PMID 11108300·Bone Marrow Transplant·2000
8-other
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation.
PMID 10871724·Bone Marrow Transplant·2000
3-trial
Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?
PMID 19421170·Bone Marrow Transplant·2010
8-other
Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation.
PMID 19450182·Future Oncol·2009
6-review
A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse.
PMID 19557633·Leuk Lymphoma·2009
8-other
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
PMID 19508292·Br J Haematol·2009
3-trial
Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation.
PMID 19377514·Bone Marrow Transplant·2009
8-other
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.
PMID 18827183·Blood·2009
8-other
Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.
PMID 18410898·Biol Blood Marrow Transplant·2008
6-review
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
PMID 18664621·Blood·2008
8-other
400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
PMID 18711346·Bone Marrow Transplant·2008
8-other
Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia.
PMID 18766970·Leuk Lymphoma·2008
8-other
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma.
PMID 18940678·Biol Blood Marrow Transplant·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 1021 MOREHEAD MEDICAL DR, STE A
CHARLOTTE, NC 28204 - Phone
- (980) 442-2000
Quick Facts
- NPI
- 1962417451
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile